MENU
ZLAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Zai Lab (ZLAB) Earnings Date & Reports

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ZLAB is expected to report earnings to rise 1,107.80% to -60 cents per share on August 10

Zai Lab ZLAB Stock Earnings Reports
Q2'26
Est.
$-0.60
Q1'26
Beat
by $0.42
Q4'25
Beat
by $0.32
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.37
The last earnings report on May 07 showed earnings per share of -5 cents, beating the estimate of -46 cents. With 177.03K shares outstanding, the current market capitalization sits at 1.95B.
View a ticker or compare two or three
ZLAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a service for cancer & autoimmune treatment

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
4560 Jinke Road
Phone
+86 2161632588
Employees
2175
Web
https://www.zailaboratory.com